Venus to supply docetaxel to Thailand under compulsory licence
This article was originally published in Scrip
Executive Summary
India's Venus Remedies is set to commence supplies of a cut-price generic version of Sanofi Aventis' anticancer Taxotere (docetaxel) to the Thai government later this year under a compulsory licence for the product.